EG240921 Inhibitors
EG240921 inhibitors are a class of chemical compounds specifically designed to block or inhibit the function of the **EG240921** protein, which is presumed to be involved in critical cellular processes such as molecular transport, enzymatic activity, or signal transduction. These inhibitors act by binding to the active or regulatory sites of EG240921, preventing it from engaging with other molecules or executing its normal biological function. By inhibiting EG240921, researchers are able to disrupt its participation in various biochemical pathways, enabling the study of how its inhibition impacts cellular systems and processes. This can provide insights into the role of EG240921 in maintaining cellular equilibrium and how its activity regulates key interactions within the cell.
The use of EG240921 inhibitors in research is vital for exploring the molecular networks that rely on the activity of this protein. Blocking EG240921 allows scientists to observe how the suppression of its function alters metabolic or signaling pathways, which can include changes in intracellular communication, energy metabolism, or protein turnover. Additionally, these inhibitors can help researchers understand the regulatory mechanisms that balance cellular functions in the presence or absence of EG240921 activity. By studying these inhibitors, scientists can also uncover potential feedback loops or compensatory responses that may arise when EG240921 is inhibited, offering a more comprehensive view of its role in cellular organization and homeostasis. Through such investigations, EG240921 inhibitors become valuable tools for mapping the complex interactions that sustain cellular function and for understanding the precise molecular roles played by proteins like EG240921.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
DNA methyltransferase inhibitor impacting Ifi206's DNA-binding transcription repressor activity. Decitabine disrupts DNA methylation, altering the cis-regulatory region sequence-specific DNA binding activity of Ifi206 and influencing its role in gene expression regulation within the nucleolus and nucleoplasm. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
HDAC inhibitor affecting Ifi206's transcription repressor activity. Vorinostat alters chromatin structure, influencing the RNA polymerase II-specific DNA binding activity of Ifi206 and modulating its role in the regulation of gene expression within the nucleolus and nucleoplasm. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
NF-κB inhibitor impacting Ifi206's involvement in the innate immune response. BAY 11-7082 influences the nucleoplasmic activities of Ifi206, disrupting its role in the regulation of innate immune responses and cysteine-type endopeptidase activity. | ||||||
Stat3 inhibitor V, stattic | 19983-44-9 | sc-202818 sc-202818A sc-202818B sc-202818C sc-202818D sc-202818E sc-202818F | 25 mg 100 mg 250 mg 500 mg 1 g 2.5 g 5 g | $130.00 $196.00 $274.00 $512.00 $731.00 $1408.00 $2091.00 | 114 | |
STAT inhibitor affecting Ifi206's participation in gene expression regulation. Stattic modulates the RNA polymerase II-specific DNA binding activity of Ifi206, altering its role in the regulation of gene expression within the nucleolus and nucleoplasm. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Nucleolar RNA polymerase inhibitor affecting Ifi206's involvement in RNA polymerase II-specific DNA binding activity. Actinomycin D disrupts nucleolar transcription, influencing Ifi206's role in the regulation of gene expression and identical protein binding activity within the nucleolus. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
RNA polymerase II cis-regulatory inhibitor affecting Ifi206's DNA binding and gene regulation. Triptolide disrupts the cis-regulatory region sequence-specific DNA binding activity of Ifi206, influencing its role in gene expression regulation within the nucleolus and nucleoplasm. | ||||||
DNA-PK Inhibitor II | 154447-35-5 | sc-202143 sc-202143A | 10 mg 50 mg | $155.00 $660.00 | 6 | |
DNA-PK inhibitor affecting Ifi206's DNA binding and gene regulation. NU7026 disrupts DNA repair mechanisms, influencing the cis-regulatory region sequence-specific DNA binding activity of Ifi206 and modulating its role in gene expression regulation within the nucleolus and nucleoplasm. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Nucleolar transport inhibitor affecting Ifi206's activities within the nucleolus. Leptomycin B disrupts the transport of nucleolar components, influencing Ifi206's role in the regulation of gene expression and identical protein binding activity within the nucleolus. | ||||||
BAY 11-7085 | 196309-76-9 | sc-202490 sc-202490A | 10 mg 50 mg | $124.00 $526.00 | 55 | |
TLR signaling pathway inhibitor impacting Ifi206's involvement in innate immune responses. BAY 11-7085 alters cytosolic signaling, influencing Ifi206's role in the regulation of innate immune responses and cysteine-type endopeptidase activity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Nucleoplasmic proteasome inhibitor affecting Ifi206's identical protein binding activity. MG-132 disrupts protein degradation within the nucleoplasm, influencing Ifi206's role in the regulation of gene expression and gene-specific protein interactions within the nucleoplasm. | ||||||